Assessment of pioglitazone and proinflammatory cytokines during buprenorphine taper in patients with opioid use disorder. - Schroeder, Jennifer R.; Phillips, Karran A.; Epstein, David H.; Jobes, Michelle L.; Furnari, Melody A.; Kennedy, Ashley P.; Heilig, Markus; Preston, Kenzie L. (Psychopharmacology, 2018)